Carrier-free prodrug nanoparticles based on dasatinib and cisplatin for efficient antitumor in vivo

Carrier-free prodrug nanoparticles based on dasatinib and cisplatin for efficient antitumor in vivo

Carrier-free drug self-delivery systems consisting of amphiphilic drug-drug conjugate (ADDC) with well-defined structure and nanoscale features have drawn much attention in tumor drug delivery. Herein, we report a simple and effective strategy to prepare ADDC using derivatives of cisplatin (CP) and...

Full description

Bibliographic Details
Main Authors: Lu Yang, Jiaxi Xu, Zheng Xie, Faquan Song, Xin Wang, Rupei Tang
Format: Article
Language:English
Published: Elsevier 2021-11-01
Series:Asian Journal of Pharmaceutical Sciences
Subjects:
Prodrug
Nanoparticle
Dasatinib
Cisplatin
Online Access:http://www.sciencedirect.com/science/article/pii/S181808762100060X

Similar Items

Similar Items